Evidence map›Paper›PMID 26553661›Full record

ArticleThe Annals of otology, rhinology, and laryngology2016

Early Cellular Response to Radiation in Human Vocal Fold Fibroblasts.

Elizabeth Erickson-DiRenzo, Gabrielle Enos, Susan L Thibeault

Open access · greenAbstract read
In one paragraph

Article in The Annals of otology, rhinology, and laryngology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elizabeth Erickson-DiRenzoDepartment of Otolaryngology- Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
Gabrielle EnosDepartment of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Wisconsin-Madison, Wisconsin, USA.
Susan L ThibeaultDepartment of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Wisconsin-Madison, Wisconsin, USA thibeault@surgery.wisc.edu.
University of Wisconsin–Madison · USStanford University · US

Funding

University of Wisconsin Voice Research Training Program (T32)T32DC009401 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI Susan Lynn Thibeault · 2009 to 2026
$6.3M
Mechanisms of innate immune-microbial interactions in vocal fold InflammationR01DC012773 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI THIBEAULT, SUSAN LYNN · 2013 to 2022
$4.5M
NIDCD NIH HHS R01 DC012773NIDCD NIH HHS T32 DC009401
6 · The paper itself

Abstract

objectivesRadiation therapy is a common treatment strategy for laryngeal carcinoma. However, radiation is not without adverse side effects, especially toward healthy vocal fold tissue, which can lead to long-term impairments in vocal function. The objective of this preliminary study was to investigate early responses of healthy human vocal fold fibroblasts (VFF) to radiation.

methodsVFF were exposed to a single or fractionated dose radiation scheme. Nonradiated VFF served as controls. Morphology of radiated and control VFF was subjectively examined. Quantitative polymerase chain reaction was used to evaluate the effect of radiation on extracellular matrix and inflammatory-related genes. VFF viability was investigated using a LIVE/DEAD and clonogenic assay.

resultsSingle or fractioned dose radiated VFF were morphologically indistinguishable from control VFF. No significant differences in gene expression were observed following either radiation scheme and as compared to controls. Clonogenic assay revealed reduced VFF viability following the fractionated but not single dose scheme. No changes in viability were detected using the LIVE/DEAD assay.

conclusionsWe present one of the first investigations to evaluate early responses of healthy VFF to radiation. Findings will contribute to a growing body of literature seeking to elucidate the biological mechanisms underlying voice changes following radiation therapy for laryngeal carcinoma.

Indexed as

Cell SurvivalDNA, NeoplasmDose Fractionation, RadiationExtracellular Matrix ProteinsFibroblastsFollow-Up StudiesGene Expression Regulation, NeoplasticHumansLaryngeal NeoplasmsMalePolymerase Chain ReactionRadiation InjuriesTime FactorsVocal CordsYoung AdultDNA, NeoplasmExtracellular Matrix Proteinscell viabilityfibroblastgene expressionradiationvocal fold

Identifiers

PMID26553661
PMCPMC5108093
OpenAlexW2177111578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.